SIRT1 and pulmonary arterial hypertension: Moreover, modulation of SIRT1 activity has been shown to restore mitochondrial biogenesis and normalize the phenotype of PASMCs, thereby offering a novel therapeutic approach to mitigate the hyperproliferation characteristic of PAH.